Amphastar Pharmaceuticals Inc logo

AMPH - Amphastar Pharmaceuticals Inc News Story

$18.81 -0.4  -1.9%

Last Trade - 18/02/20

Sector
Healthcare
Size
Mid Cap
Market Cap £691.8m
Enterprise Value £684.9m
Revenue £252.7m
Position in Universe 2515th / 6408

BRIEF-Amphastar Pharma Posts Q3 Adj Earnings Per Share Of $0.10

Thu 7th November, 2019 10:21pm
Nov 7 (Reuters) - Amphastar Pharmaceuticals Inc  AMPH.O :
    * AMPHASTAR PHARMACEUTICALS REPORTS FINANCIAL RESULTS FOR
THE
THREE MONTHS ENDED SEPTEMBER 30, 2019
    * Q3 REVENUE $80.1 MILLION VERSUS REFINITIV IBES ESTIMATE OF
$78.5
MILLION
    * Q3 GAAP EARNINGS PER SHARE $0.03
    * Q3 EARNINGS PER SHARE ESTIMATE $0.07 -- REFINITIV IBES
DATA
    * Q3 ADJUSTED NON-GAAP EARNINGS PER SHARE $0.10
    * ON NOVEMBER 4, 2019, COMPANY'S BOARD OF DIRECTORS
AUTHORIZED AN
INCREASE OF $20 MILLION TO COMPANY'S SHARE BUYBACK PROGRAM
    * QTRLY EARNINGS PER SHARE $0.03

Source text for Eikon:  ID:nGNX7BPh4H 
Further company coverage:  AMPH.O 

 ((Reuters.Briefs@thomsonreuters.com;))
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.